Can Pre-operative Flexible 3D Models of Pulmonary Malformations Facilitate Thoracoscopic Resection (3DLP)
Primary Purpose
Pulmonary Malformation
Status
Not yet recruiting
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
3D printed model
Control group
Sponsored by
About this trial
This is an interventional treatment trial for Pulmonary Malformation focused on measuring pulmonary malformation, 3D printed models, thoracotomy, thoracoscopy children
Eligibility Criteria
Inclusion Criteria:
- Patients aged from 1 day to 24 months.
- Patients with pulmonary malformation eligible for surgery
- Parents agreement for surgical treatment
- Parents able to sign an informed consent form
- Patient benefiting from a social insurance system or a similar system
Exclusion Criteria:
- Emergency surgeries (less than 15 days between scanner and surgery)
- Obvious extrapulmonary sequestration on tomographic scanning images
- Patients with other major malformation additionally to pulmonary malformation
- Parents unable to understand the purpose of the trial
- Patient already participating to another clinical trial that might jeopardize the current trial
Sites / Locations
- Hopital Femme Mere Enfant
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Other
Arm Label
3D
Control group
Arm Description
Surgery with surgeon trained using a 3D printed model of the pulmonary malformation.
Conventional surgery without training using a 3D printed model of the pulmonary malformation.
Outcomes
Primary Outcome Measures
proportion of intent to treat under thoracoscopy vs thoracotomy procedures
Comparisonbetween the 2 groups.
Secondary Outcome Measures
conversion rate from thoracoscopy over thoracoscopy attempted.
Comparison between the 2 groups.
Proportion of effective pulmonary exclusion of the operated lung.
Proportion of variation between preoperative and effective strategy
Variation of strategy in terms of type of resection (lobar, sub-lobar or segmental resection)
induction time
Comparison of induction time in minutes between the 2 strategies
Evaluation of pain using EVENDOL scale
Comparison of pain between the 2 groups. Total EVENDOL scores vary from 0 (min) to 15 (max). Each item is scored from 0 to 3 0 = No sign, normal
= weak or transient sign
= moderate or only present half the time
= strong or almost permanent sign
Evaluation of pain using EVENDOL scale
Comparison of pain between the 2 groups. Total EVENDOL scores vary from 0 (min) to 15 (max). Each item is scored from 0 to 3 0 = No sign, normal
= weak or transient sign
= moderate or only present half the time
= strong or almost permanent sign
Evaluation of pain using EVENDOL scale
Comparison of pain between the 2 groups. Total EVENDOL scores vary from 0 (min) to 15 (max). Each item is scored from 0 to 3 0 = No sign, normal
= weak or transient sign
= moderate or only present half the time
= strong or almost permanent sign
Evaluation of pain using EVENDOL scale
Comparison of pain between the 2 groups. Total EVENDOL scores vary from 0 (min) to 15 (max). Each item is scored from 0 to 3 0 = No sign, normal
= weak or transient sign
= moderate or only present half the time
= strong or almost permanent sign
Evaluation of pain using EVENDOL scale
Comparison of pain between the 2 groups. Total EVENDOL scores vary from 0 (min) to 15 (max). Each item is scored from 0 to 3 0 = No sign, normal
= weak or transient sign
= moderate or only present half the time
= strong or almost permanent sign
percentage of analgesic treatments
Comparison of Analgesic consumption between the 2 groups
Blood loss
Comparison of Blood loss in ml between the 2 groups
number of residual lesions assessed on TDM scanner images
number of complications (duration of postoperative air leak greater than 5 days)
number of complications (reoperation)
number of complications (pneumothorax).
Drainage duration
Comparison between the 2 groups of drainage duration in days (drain removal when loss lower than 50ml)
Length of hospital stay
Comparison between the 2 groups of Length of hospital stay in days
resection complexity classification
Development of a resection complexity classification similar to the PreText classification of hepatoblastoma
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT03913416
Brief Title
Can Pre-operative Flexible 3D Models of Pulmonary Malformations Facilitate Thoracoscopic Resection
Acronym
3DLP
Official Title
Can Pre-operative Flexible 3D Models of Pulmonary Malformations Facilitate Thoracoscopic Resection
Study Type
Interventional
2. Study Status
Record Verification Date
March 2020
Overall Recruitment Status
Not yet recruiting
Study Start Date
September 2020 (Anticipated)
Primary Completion Date
September 2024 (Anticipated)
Study Completion Date
September 2024 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Hospices Civils de Lyon
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The National Rare Diseases plans, the ongoing MALFPULM PHRC and thoracoscopic advents in children, are remarkable improvements in understanding and managing lung malformations. The resection of these malformations is now proposed in most cases to avoid infections which are difficult to treat and to diagnose or to avoid exceptional tumors. Procedures are ideally performed around the age of 5-6 months to take advantage of the lung growth that continues during the first two years of life. The surgical strategies depend of the malformation size, the tumor risk and surgeon choice: conservative surgery with removal of part of the lobe may be preferred over complete resection of the concerned lobe.
If possible, thoracoscopic resection is carried out. The open thoracotomy is more painful and leads to complications such as thoracic deformities, larger scars, blood loss. However, in infants the thoracoscopic work space is small, lung exclusion is challenging and the anatomy (normal or malformative) is difficult to understand in space. The rate of thoracoscopy without conversion to thoracotomy ranges from 98% in one American center with a more radical approach , to 48% in a national cohort. Pulmonary exclusion failure, complexity and size of malformations and intra-operative complications are factors of conversion to thoracotomy . These factors can lead surgeons to perform thoracotomy without attempting thoracoscopy.
3D printing is a thriving research field for its educational or therapeutic potential optimization of management, prosthesis, and organ replacement. 3D printing is particularly adapted to pediatrics, which suffers from the rarity of its pathologies and a large spectrum of size and morphology prohibiting the mass production of models. 3D printing models of complex pulmonary pathologies will allowed for a better anesthetic and surgical approach. The modeling of bronchial, vascular and even parenchymatous anatomy permits a better understanding of the anatomical particularities of each patient. This, in turn, avoids the intra-operative conversions to thoracotomy with a direct benefit for the patient.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pulmonary Malformation
Keywords
pulmonary malformation, 3D printed models, thoracotomy, thoracoscopy children
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
178 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
3D
Arm Type
Experimental
Arm Description
Surgery with surgeon trained using a 3D printed model of the pulmonary malformation.
Arm Title
Control group
Arm Type
Other
Arm Description
Conventional surgery without training using a 3D printed model of the pulmonary malformation.
Intervention Type
Device
Intervention Name(s)
3D printed model
Intervention Description
Before surgery, the surgeon will have a 3D printed model of the pulmonary malformation as well as the lung, the rib cage and the tracheal trunk based on the initial scanner images. He will then be able to train and plan the surgical strategy, as well as to discuss the pulmonary exclusion with the anesthetist.
Intervention Type
Other
Intervention Name(s)
Control group
Intervention Description
The control group is composed of patients operated with standard surgery
Primary Outcome Measure Information:
Title
proportion of intent to treat under thoracoscopy vs thoracotomy procedures
Description
Comparisonbetween the 2 groups.
Time Frame
Day 1
Secondary Outcome Measure Information:
Title
conversion rate from thoracoscopy over thoracoscopy attempted.
Description
Comparison between the 2 groups.
Time Frame
Day 1
Title
Proportion of effective pulmonary exclusion of the operated lung.
Time Frame
Day 1
Title
Proportion of variation between preoperative and effective strategy
Description
Variation of strategy in terms of type of resection (lobar, sub-lobar or segmental resection)
Time Frame
Day 1
Title
induction time
Description
Comparison of induction time in minutes between the 2 strategies
Time Frame
Day 1
Title
Evaluation of pain using EVENDOL scale
Description
Comparison of pain between the 2 groups. Total EVENDOL scores vary from 0 (min) to 15 (max). Each item is scored from 0 to 3 0 = No sign, normal
= weak or transient sign
= moderate or only present half the time
= strong or almost permanent sign
Time Frame
Hour 12
Title
Evaluation of pain using EVENDOL scale
Description
Comparison of pain between the 2 groups. Total EVENDOL scores vary from 0 (min) to 15 (max). Each item is scored from 0 to 3 0 = No sign, normal
= weak or transient sign
= moderate or only present half the time
= strong or almost permanent sign
Time Frame
Hour 24
Title
Evaluation of pain using EVENDOL scale
Description
Comparison of pain between the 2 groups. Total EVENDOL scores vary from 0 (min) to 15 (max). Each item is scored from 0 to 3 0 = No sign, normal
= weak or transient sign
= moderate or only present half the time
= strong or almost permanent sign
Time Frame
Hour 36
Title
Evaluation of pain using EVENDOL scale
Description
Comparison of pain between the 2 groups. Total EVENDOL scores vary from 0 (min) to 15 (max). Each item is scored from 0 to 3 0 = No sign, normal
= weak or transient sign
= moderate or only present half the time
= strong or almost permanent sign
Time Frame
Hour 48
Title
Evaluation of pain using EVENDOL scale
Description
Comparison of pain between the 2 groups. Total EVENDOL scores vary from 0 (min) to 15 (max). Each item is scored from 0 to 3 0 = No sign, normal
= weak or transient sign
= moderate or only present half the time
= strong or almost permanent sign
Time Frame
Hour 72
Title
percentage of analgesic treatments
Description
Comparison of Analgesic consumption between the 2 groups
Time Frame
Day 10
Title
Blood loss
Description
Comparison of Blood loss in ml between the 2 groups
Time Frame
Day 1
Title
number of residual lesions assessed on TDM scanner images
Time Frame
1 year
Title
number of complications (duration of postoperative air leak greater than 5 days)
Time Frame
Day 10
Title
number of complications (reoperation)
Time Frame
Day 10
Title
number of complications (pneumothorax).
Time Frame
Day 10
Title
Drainage duration
Description
Comparison between the 2 groups of drainage duration in days (drain removal when loss lower than 50ml)
Time Frame
Day 10
Title
Length of hospital stay
Description
Comparison between the 2 groups of Length of hospital stay in days
Time Frame
Day 10
Title
resection complexity classification
Description
Development of a resection complexity classification similar to the PreText classification of hepatoblastoma
Time Frame
Day 10
10. Eligibility
Sex
All
Minimum Age & Unit of Time
1 Day
Maximum Age & Unit of Time
24 Months
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients aged from 1 day to 24 months.
Patients with pulmonary malformation eligible for surgery
Parents agreement for surgical treatment
Parents able to sign an informed consent form
Patient benefiting from a social insurance system or a similar system
Exclusion Criteria:
Emergency surgeries (less than 15 days between scanner and surgery)
Obvious extrapulmonary sequestration on tomographic scanning images
Patients with other major malformation additionally to pulmonary malformation
Parents unable to understand the purpose of the trial
Patient already participating to another clinical trial that might jeopardize the current trial
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Frederic Hameury, MD
Phone
4 27 85 57 89
Ext
+33
Email
julien.berthiller@chu-lyon.fr
First Name & Middle Initial & Last Name or Official Title & Degree
Julien BERTHILLER
Phone
4 72 11 80 67
Ext
+33
Email
julien.berthiller@chu-lyon.fr
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Frederic Hameury, MD
Organizational Affiliation
Hospices Civils de Lyon
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hopital Femme Mere Enfant
City
Bron
Country
France
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Frederic Hameury, MD
Phone
4 27 85 57 89
Ext
+33
12. IPD Sharing Statement
Learn more about this trial
Can Pre-operative Flexible 3D Models of Pulmonary Malformations Facilitate Thoracoscopic Resection
We'll reach out to this number within 24 hrs